Seres Therapeutics, Inc.
Profit History
| Fiscal Year | Revenue | Operating Income | Net Income |
|---|---|---|---|
| FY2013 | — | $-6.1M | $-6.1M |
| FY2014 | — | $-15.1M | $-16.7M |
| FY2015 | $0 | $-54.9M | $-54.8M |
| FY2016 | $21.8M | $-92.8M | $-91.6M |
| FY2017 | $32.1M | $-91.4M | $-89.4M |
| FY2018 | $28.3M | $-100.3M | $-98.9M |
| FY2019 | $34.5M | $-71.9M | $-70.3M |
| FY2020 | $33.2M | $-88.1M | $-89.1M |
| FY2021 | $144.9M | $-64.5M | $-65.6M |
| FY2022 | $7.1M | $-179.9M | $-250.2M |
| FY2023 | $0 | $-195.1M | $-113.7M |
| FY2024 | $0 | $-121.3M | $136.0K |
| FY2025 | $789.0K | $-94.0M | $5.7M |